Contact Information: For further information contact: David Carey Lazar Partners Ltd. 212-867-1768
Electro-Optical Sciences Announces Participation at the Oppenheimer 20th Annual Healthcare Conference
| Source: Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - October 22, 2009) - Electro-Optical Sciences, Inc. ("EOS")
(NASDAQ : MELA ), today announced that Joseph V. Gulfo, MD, president and
chief executive officer, will present at the Oppenheimer 20th Annual
Healthcare Conference taking place at The Waldorf=Astoria in New York City
November 3-4, 2009.
Dr. Gulfo's presentation is scheduled for Wednesday, November 4th at 3:55pm
ET. To access the live webcast of this presentation, visit
www.eosciences.com. A replay of this presentation will be available on the
company's website for thirty days following the presentation.
About Electro-Optical Sciences
Electro-Optical Sciences is a medical technology company focused on
developing MelaFind®, a non-invasive and objective computer vision system
intended to aid in the early detection of melanoma. EOS designed
MelaFind® to assist in the evaluation of pigmented skin lesions,
including atypical moles, which have one or more clinical or historical
characteristics of melanoma, before a final decision to biopsy has been
rendered. MelaFind® acquires and displays multi-spectral (from blue to
near infrared) digital images of pigmented skin lesions and uses automatic
image analysis and statistical pattern recognition to help identify lesions
to be considered for biopsy to rule out melanoma.
Although the MelaFind® PMA is subject to the FDA's expedited review
procedures, EOS cannot predict either the timing of the FDA's decision on
the PMA application or the outcome. FDA approval is required prior to
marketing MelaFind® in the United States.
For more information on EOS, visit www.eosciences.com.
Safe Harbor
This press release includes "forward-looking statements" within the meaning
of the Securities Litigation Reform Act of 1995. These statements include
but are not limited to our plans, objectives, expectations and intentions
and other statements that contain words such as "expects," "contemplates,"
"anticipates," "plans," "intends," "believes" and variations of such words
or similar expressions that predict or indicate future events or trends, or
that do not relate to historical matters. These statements are based on our
current beliefs or expectations and are inherently subject to significant
uncertainties and changes in circumstances, many of which are beyond our
control. There can be no assurance that our beliefs or expectations will be
achieved. Actual results may differ materially from our beliefs or
expectations due to economic, business, competitive, market and regulatory
factors.